---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-022604"
form_type: "8-K"
ticker: "RNLXY"
cik: "0001811115"
company_name: "Renalytix plc"
filed_at: "2024-02-29T23:59:59+00:00"
generated_at: "2026-06-05T07:13:47.671183+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Renalytix secures 10-year US government contract; Medicare coverage decision pending

## Summary
- KidneyIntelX.dkd added to 10-year GWAC through GSA, covering VA, DoD, IHS, at $950/result.
- NGS holds Open Public Meeting on proposed coverage policy DL39726; final LCD expected FY2024.
- Effective Jan 1, 2024, test priced at $950 on CMS CLFS for three years.
- These advancements expected to enable insurance coverage for 10M of 14M FDA-indicated patients.

## SEC filing metadata
- accession: 0000950170-24-022604
- form_type: 8-K
- ticker: RNLXY
- cik: 0001811115
- company_name: Renalytix plc
- filed_at: 2024-02-29T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1811115/000095017024022604/0000950170-24-022604-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1811115/000095017024022604/rnlx-20240229.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-022604
- JSON: https://secwatch.observer/filing/0000950170-24-022604.json
- Plain text: https://secwatch.observer/filing/0000950170-24-022604.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.